CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY
This study was aimed to correlatethe inflammation parameters with peripheral neuropathic pain in patientsunderwent paclitaxel chemotherapy after diagnosed with breast cancer. Histopathologically, patients who were diagnosed with breast cancer and received adjuvant paclitaxel treatment in the medical...
Gespeichert in:
Veröffentlicht in: | Fresenius environmental bulletin 2021-07, Vol.30 (7A), p.9547 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 7A |
container_start_page | 9547 |
container_title | Fresenius environmental bulletin |
container_volume | 30 |
creator | Gundogdu, Utku Donem Cenikli, Utku Coban, Funda Karabag Tanriverdi, Ozgur |
description | This study was aimed to correlatethe inflammation parameters with peripheral neuropathic pain in patientsunderwent paclitaxel chemotherapy after diagnosed with breast cancer. Histopathologically, patients who were diagnosed with breast cancer and received adjuvant paclitaxel treatment in the medical oncology clinic fromMarch 2019 to January were included in the study. These patients had operated breast cancer and received weekly adjuvant paclitaxel treatment neuropathic pain questionnaire. A total of 64 patients were included in this study where 42 (65.6%) of them had no neuropathy while 22 (34.4) had neuropathy. The general average age was 50.42 (SD: 10) where the oldest person was 73 years old while the youngest one was 29.No significant difference was found between the mean age of the patients with neuropathy and the mean age of the patients without it. There was also no statistical significancedifference in I, II measurements of NLR and TLR variables between the groups with and without neutropathy. No relationship was found between docetaxel-induced neuropathy and neutrophil/lymphocyte parameters in patients with neuropathic pain. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2557866945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2557866945</sourcerecordid><originalsourceid>FETCH-LOGICAL-p113t-3e24ef5dcdfc962c9dfd910df52de6a44f35e50eaae4fc97fcf66cccc03ba1493</originalsourceid><addsrcrecordid>eNotjc1qwzAQhE1poSHNOwh6Nug_8VFVlVggS0aRSXsKri0dQmnSOHmKvnRV0rnszDL77V0xQxzBEhNI77OHaFVSjqrHYjFNB5jF8RJzMit-pPNeGRG0s8CtgbZrI5rmllvhRaOC8luw06EGrfK6rZUXBljVedeKUGuZa9rmQ_DildgGIIWVyudt0MqGLejsq_K7bEGoves2mSOk0UG8KQNkrRoX_pjt-1PxkPrPKS7-57zo1irIujRuo6Uw5QkhcilJxDQmNg5jGiqOh2pMY4XgmBgeI-8pTYRFBmPfR5obyzQkzocsSD56RCsyL55v3NP5-H2N02V_OF7PX_nlHjO2XHFeUUZ-Ad4_V2c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2557866945</pqid></control><display><type>article</type><title>CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Gundogdu, Utku Donem ; Cenikli, Utku ; Coban, Funda Karabag ; Tanriverdi, Ozgur</creator><creatorcontrib>Gundogdu, Utku Donem ; Cenikli, Utku ; Coban, Funda Karabag ; Tanriverdi, Ozgur</creatorcontrib><description>This study was aimed to correlatethe inflammation parameters with peripheral neuropathic pain in patientsunderwent paclitaxel chemotherapy after diagnosed with breast cancer. Histopathologically, patients who were diagnosed with breast cancer and received adjuvant paclitaxel treatment in the medical oncology clinic fromMarch 2019 to January were included in the study. These patients had operated breast cancer and received weekly adjuvant paclitaxel treatment neuropathic pain questionnaire. A total of 64 patients were included in this study where 42 (65.6%) of them had no neuropathy while 22 (34.4) had neuropathy. The general average age was 50.42 (SD: 10) where the oldest person was 73 years old while the youngest one was 29.No significant difference was found between the mean age of the patients with neuropathy and the mean age of the patients without it. There was also no statistical significancedifference in I, II measurements of NLR and TLR variables between the groups with and without neutropathy. No relationship was found between docetaxel-induced neuropathy and neutrophil/lymphocyte parameters in patients with neuropathic pain.</description><identifier>ISSN: 1018-4619</identifier><identifier>EISSN: 1610-2304</identifier><language>eng</language><publisher>Freising: Parlar Scientific Publications</publisher><subject>Age ; Breast cancer ; Chemotherapy ; Inflammation ; Leukocytes (neutrophilic) ; Lymphocytes ; Mean ; Paclitaxel ; Pain ; Parameters ; Patients ; Peripheral neuropathy</subject><ispartof>Fresenius environmental bulletin, 2021-07, Vol.30 (7A), p.9547</ispartof><rights>Copyright Parlar Scientific Publications Jul 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Gundogdu, Utku Donem</creatorcontrib><creatorcontrib>Cenikli, Utku</creatorcontrib><creatorcontrib>Coban, Funda Karabag</creatorcontrib><creatorcontrib>Tanriverdi, Ozgur</creatorcontrib><title>CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY</title><title>Fresenius environmental bulletin</title><description>This study was aimed to correlatethe inflammation parameters with peripheral neuropathic pain in patientsunderwent paclitaxel chemotherapy after diagnosed with breast cancer. Histopathologically, patients who were diagnosed with breast cancer and received adjuvant paclitaxel treatment in the medical oncology clinic fromMarch 2019 to January were included in the study. These patients had operated breast cancer and received weekly adjuvant paclitaxel treatment neuropathic pain questionnaire. A total of 64 patients were included in this study where 42 (65.6%) of them had no neuropathy while 22 (34.4) had neuropathy. The general average age was 50.42 (SD: 10) where the oldest person was 73 years old while the youngest one was 29.No significant difference was found between the mean age of the patients with neuropathy and the mean age of the patients without it. There was also no statistical significancedifference in I, II measurements of NLR and TLR variables between the groups with and without neutropathy. No relationship was found between docetaxel-induced neuropathy and neutrophil/lymphocyte parameters in patients with neuropathic pain.</description><subject>Age</subject><subject>Breast cancer</subject><subject>Chemotherapy</subject><subject>Inflammation</subject><subject>Leukocytes (neutrophilic)</subject><subject>Lymphocytes</subject><subject>Mean</subject><subject>Paclitaxel</subject><subject>Pain</subject><subject>Parameters</subject><subject>Patients</subject><subject>Peripheral neuropathy</subject><issn>1018-4619</issn><issn>1610-2304</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotjc1qwzAQhE1poSHNOwh6Nug_8VFVlVggS0aRSXsKri0dQmnSOHmKvnRV0rnszDL77V0xQxzBEhNI77OHaFVSjqrHYjFNB5jF8RJzMit-pPNeGRG0s8CtgbZrI5rmllvhRaOC8luw06EGrfK6rZUXBljVedeKUGuZa9rmQ_DildgGIIWVyudt0MqGLejsq_K7bEGoves2mSOk0UG8KQNkrRoX_pjt-1PxkPrPKS7-57zo1irIujRuo6Uw5QkhcilJxDQmNg5jGiqOh2pMY4XgmBgeI-8pTYRFBmPfR5obyzQkzocsSD56RCsyL55v3NP5-H2N02V_OF7PX_nlHjO2XHFeUUZ-Ad4_V2c</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Gundogdu, Utku Donem</creator><creator>Cenikli, Utku</creator><creator>Coban, Funda Karabag</creator><creator>Tanriverdi, Ozgur</creator><general>Parlar Scientific Publications</general><scope>7ST</scope><scope>7T7</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>SOI</scope></search><sort><creationdate>20210701</creationdate><title>CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY</title><author>Gundogdu, Utku Donem ; Cenikli, Utku ; Coban, Funda Karabag ; Tanriverdi, Ozgur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p113t-3e24ef5dcdfc962c9dfd910df52de6a44f35e50eaae4fc97fcf66cccc03ba1493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age</topic><topic>Breast cancer</topic><topic>Chemotherapy</topic><topic>Inflammation</topic><topic>Leukocytes (neutrophilic)</topic><topic>Lymphocytes</topic><topic>Mean</topic><topic>Paclitaxel</topic><topic>Pain</topic><topic>Parameters</topic><topic>Patients</topic><topic>Peripheral neuropathy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gundogdu, Utku Donem</creatorcontrib><creatorcontrib>Cenikli, Utku</creatorcontrib><creatorcontrib>Coban, Funda Karabag</creatorcontrib><creatorcontrib>Tanriverdi, Ozgur</creatorcontrib><collection>Environment Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environment Abstracts</collection><jtitle>Fresenius environmental bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gundogdu, Utku Donem</au><au>Cenikli, Utku</au><au>Coban, Funda Karabag</au><au>Tanriverdi, Ozgur</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY</atitle><jtitle>Fresenius environmental bulletin</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>30</volume><issue>7A</issue><spage>9547</spage><pages>9547-</pages><issn>1018-4619</issn><eissn>1610-2304</eissn><abstract>This study was aimed to correlatethe inflammation parameters with peripheral neuropathic pain in patientsunderwent paclitaxel chemotherapy after diagnosed with breast cancer. Histopathologically, patients who were diagnosed with breast cancer and received adjuvant paclitaxel treatment in the medical oncology clinic fromMarch 2019 to January were included in the study. These patients had operated breast cancer and received weekly adjuvant paclitaxel treatment neuropathic pain questionnaire. A total of 64 patients were included in this study where 42 (65.6%) of them had no neuropathy while 22 (34.4) had neuropathy. The general average age was 50.42 (SD: 10) where the oldest person was 73 years old while the youngest one was 29.No significant difference was found between the mean age of the patients with neuropathy and the mean age of the patients without it. There was also no statistical significancedifference in I, II measurements of NLR and TLR variables between the groups with and without neutropathy. No relationship was found between docetaxel-induced neuropathy and neutrophil/lymphocyte parameters in patients with neuropathic pain.</abstract><cop>Freising</cop><pub>Parlar Scientific Publications</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1018-4619 |
ispartof | Fresenius environmental bulletin, 2021-07, Vol.30 (7A), p.9547 |
issn | 1018-4619 1610-2304 |
language | eng |
recordid | cdi_proquest_journals_2557866945 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Age Breast cancer Chemotherapy Inflammation Leukocytes (neutrophilic) Lymphocytes Mean Paclitaxel Pain Parameters Patients Peripheral neuropathy |
title | CORRELATION OF INFLAMMATION PARAMETERS WITH PERIPHERAL NEUROPATHIC PAIN IN BREAST CANCER PATIENTS UNDERWENT THROUGH PACLITAXEL CHEMOTHERAPY |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T06%3A39%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CORRELATION%20OF%20INFLAMMATION%20PARAMETERS%20WITH%20PERIPHERAL%20NEUROPATHIC%20PAIN%20IN%20BREAST%20CANCER%20PATIENTS%20UNDERWENT%20THROUGH%20PACLITAXEL%20CHEMOTHERAPY&rft.jtitle=Fresenius%20environmental%20bulletin&rft.au=Gundogdu,%20Utku%20Donem&rft.date=2021-07-01&rft.volume=30&rft.issue=7A&rft.spage=9547&rft.pages=9547-&rft.issn=1018-4619&rft.eissn=1610-2304&rft_id=info:doi/&rft_dat=%3Cproquest%3E2557866945%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2557866945&rft_id=info:pmid/&rfr_iscdi=true |